What are you looking for ?
Infinidat
Articles_top

BioRx/Diplomat: MyFactor App for iOS and Android for Hemophilia Patients

Enabled with cloud-based storage and synchronization across multiple devices.

BioRx LLC, a Diplomat Pharmacy, Inc company, announced its version of the MyFactor app for iOS and Android mobile devices.

my-factor

These versions of the app are available for download on the App Store and Google Play.

MyFactor enables hemophilia patients to record bleeding episodes and treatments, and facilitates easy sharing of information with their health care team, including caregivers, physicians, pharmacists and nurses.

This version provides cloud-based storage and synchronization across multiple mobile devices, allowing caregivers to view multiple patients’ data on a single device.

Unlike most hemophilia apps available on the market, MyFactor now provides the confidence of secure cloud-based storage,” said Eric Hill, VP, COO, Diplomat Specialty Infusion Group. “As users increasingly upgrade, add or change mobile devices, safeguarding the continuity of their data becomes imperative. The new MyFactor ensures users can access their data on any device that runs the app.

While the new iOS app effectively replaces the original iOS release in 2013, the original app remains available on the App Store, renamed ‘MyFactor Classic.’

It has been updated to include a ‘data export’ feature (available in the app’s ‘Profile’ section). This feature allows users of the original iOS app to migrate their data to the new app and, with the addition of an email address, benefit from secure, cloud-based storage. MyFactor Classic will remain on the App Store for an undetermined period to allow time for users to convert. Apple iOS users can find instructions for exporting their data to the new version at biorxhemophilia.com/myfactor. Users of the current Android app need to download the update from Google Play and add their email address in the profile section to enable cloud-based backup.

We are excited to release this innovative app as a way to better support our patients with hemophilia or any other related bleeding disorders,” said Phil Hagerman, CEO and chairman, Diplomat. “This platform allows a revolutionary way for patients to stay on track with their treatment and share information with members of their health care team.

BioRx was acquired by Diplomat in 2015.

Articles_bottom
AIC
ATTO
OPEN-E